Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Summit Therapeutics (SMMT) EBT Margin (2022 - 2024)

Summit Therapeutics' EBT Margin history spans 2 years, with the latest figure at 2021.89% for Q2 2024.

  • For Q2 2024, EBT Margin changed N/A year-over-year to 2021.89%; the TTM value through Dec 2024 reached 3771.24%, changed N/A, while the annual FY2022 figure was 11174.75%, 627691.0% down from the prior year.
  • EBT Margin reached 2021.89% in Q2 2024 per SMMT's latest filing, up from 1458.19% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 2021.89% in Q2 2024 to a low of 7700.0% in Q3 2022.